GLYCOREX TRANSPLANTATION AB has a total of 25 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Sweden, United States and EPO (European Patent Office). Its main competitors in its focus markets chemical engineering, medical technology and measurement are IMRE CORP, BIOSEPRA INC and EP MINERALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Sweden | 7 | |
#2 | United States | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Chemical engineering | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Pharmaceuticals | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Chemical or physical processes | |
#3 | Separation | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Peptides | |
#7 | Sugars | |
#8 | Compounds of unknown constitution | |
#9 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Kurt | 20 |
#2 | Nilsson Rune | 2 |
#3 | Nilsson Kurt G I | 2 |
#4 | Sandberg Bengt | 1 |
#5 | Kronblad Åsa | 1 |
#6 | Nilsson Kurt G L | 1 |
#7 | Sandberg Bengt E B | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019172836A1 | A protein-binding product, a device contaning said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma | |
US2014255409A1 | Method for extracorporeal elimination of one or more components from blood | |
EP2734844A1 | Method for the detection of an analyte in a sample | |
US7700746B2 | Filtration material | |
US7014049B2 | Device for bio-affinity material | |
CA2366469A1 | Oligosaccharide supports for e.g. removal of antibodies from blood |